The first commercial flight, connecting two Floridian cities, celebrated its 110th anniversary this year. Since that milestone, the aviation industry has grown at a wicked pace and has become an integral part of our global economy. However, despite its expansion and economic significance, the industry has historically struggled with profitability, often facing high operational costs and tight margins and comes with significant environmental consequences.

Although global aviation is often cited as responsible for “only” 2.5% of worldwide emissions, it is the world’s wealthiest that account for 90% of emissions from air travel. And most of the air travel occurs between high and upper-middle-income countries, where alternative, lower-emission travel infrastructure is widely available (e.g. train, bus, etc.).  

The map below illustrates the concentration of per capita CO₂ emissions from domestic flights, pinpointing the countries where domestic air travel is (too) common: the U.S., Australia, Norway, New Zealand and Canada, all high-income countries. Though some of these countries are large, the travellers do have alternative options to hopping on a plane.

Indeed, air travel is sometimes necessary, but short distance flights as shown in the table below are by far the most CO₂ intensive option.

Despite this emission burden, air travel remains extremely popular. The number of flights performed annually has nearly doubled over the past twenty years, contracting only during the COVID years.  The International Air Transport Association (IATA) forecasts that air travel will double again by 2040. It goes without saying that the concurrent carbon emissions would be disastrous for efforts to mitigate climate change.

As awareness about the air travel’s emissions grows, it is perhaps not surprising that forty of the largest airlines have committed to some form of emission reduction, with 29 pledging to achieve net-zero emissions by 2050. Unfortunately, progress has been minimal. Eight airlines had pledged to submit a net-zero target for validation by the Science-Based Target initiative (SBTi), but only Delta Air Lines remains committed, likely because its target is yet to be validated while all others have missed their deadlines, essentially invalidating the process.

Boarding the Eco-Friendly Class: No One’s At the Gate

In 2021, The International Air Transport Association (IATA), representing over 330 airlines and 80% of global air traffic, approved a resolution for the global air transport industry to achieve net-zero carbon emissions by 2050. Its strategy towards net-zero emissions is based on a combination of technologies, highlighted in the chart below.  

 

We are extremely suspicious of the plan: Sustainable Aviation Fuel (SAF), hydrogen, and electric planes face extreme technological, cost, and scaling obstacles. Even if SAF really can reduce up to 80% of emissions compared to traditional jet fuel, in 2023, it only amounted to 0.2% of all aviation fuel available. Additional strategies, such as upgrading air traffic management and carbon capture, are costly and slow to implement, while offsets remain controversial as they don’t reduce direct aviation emissions. Many airlines have faced accusations of 'greenwashing,' because none have been able to substantiate their claims of being a truly sustainable mode of transportation.

In sum, none of the global airline carriers have been able to set themselves apart from the competition as leaders in low-emission air travel. This highlights the need for regulatory action.

The table below summarizes the key regulation that is in play in critical jurisdictions, aimed at curbing short haul flights in regions where other forms of travel are possible and/or desirable (i.e. mostly in Europe). In this sense, regulation has some potential to penalize short-haul, low-cost carriers, albeit so far, the evidence that this is working is weak.

 

Flying Through Operational Storms

While we found little to distinguish leaders from laggards based on airlines’ carbon reduction plans, there are nonetheless wide gaps when taking account of broader sustainability issues for airline companies. According to SASB, there are four material topics for the airlines industry: GHG emissions, labor practices, competitive behavior, and critical incident risk management. Indeed, controversies have often arisen in these areas, impacting public perception and operational stability (see the table below).

No clear leaders emerge, as these issues are widespread within the industry, underscoring the sector’s difficulty in upholding consistent standards.
 

Landing Lights: Charting Sustainability Leaders and Laggards

Focusing on material issues and being careful to consider controversies in these areas does prove instructive for deciphering airline leaders vs. laggards. The table below is the output of our analysis of the forty largest publicly listed airline companies. We use our proprietary materiality ranking, that relies on CSRHub scores for relevant topics only, i.e. those related to emissions, labor, ethics and risk management.

 We then retain those companies with CSR hub adjusted scores in the 70th percentile as potential long candidates and those with adjusted scores below the 60th percentile as potential shorts. We also remove any companies from our potential winner list with material controversies.

Except for Alaska Air and EasyJet, all of the long candidates are full-service airline companies, while the bulk of the short candidates are short haul, discount carriers or private jet companies.

A Long/Short Approach

The passenger airline industry is notoriously difficult for equity investors to navigate. Despite being very sensitive to economic cycles, airline stocks routinely underperform in pro-cyclical environments. The industry is capital intensive, labor intensive and largely a commodity-type business whereby passengers are very price conscious. The chart below shows the historical performance of select U.S. airlines (the top ten holdings of U.S. Global Jets ETF are U.S. holdings) over the past nine years; even ignoring the disastrous COVID period, U.S. airlines have only rare bouts of market outperformance and have failed to keep pace with benchmark returns since COVID.

We find no compelling argument to overweight airline stocks from neither a sustainability nor a performance perspective. Therefore, investors should look to opportunistically short sustainability laggards, or at best, explore pair trades between leaders and laggards.

One of the most important metrics for the airline industry is the load factor (i.e. the capacity utilization).  This is measured as Revenue Passenger Miles (RPM) divided by Available Seat Miles (ASM). This ratio represents the number of paying passengers flown one mile divided by the total number of seats (whether occupied or empty) flown one mile. This metric shows how efficiently an airline fills its seats. When load factors are high (i.e. above 80%), the demand for seats is high enough to favour pricing and profitability. Conversely, when load factors are low (below 80%), airplanes fly with more empty seats than is optimal.

In general, low-cost airlines – which tend to provide only short and medium haul flights - need a higher load factor to stay profitable, since, by offering lower prices, they need to sell more seats. Full-service airlines, which tend to offer a mix of short, medium and long-haul flights can be profitable at a lower load factor since each seat generates more revenue (there are very low marginal costs associated with each additional passenger).

In the chart below, we show that since 2019, full-service U.S. airlines have had a higher load factor than low-cost carriers. In other words, they have higher utilization rates at higher ticket prices.  Indeed, in the post-pandemic period, full-service U.S. carriers have eked out higher operating profits than their discount peers.

Some pundits expect this to change, arguing overcapacity issues that have plagued the industry since 2020 may now be behind us. We remain skeptical, since any slowdown in economic activity would once again curb demand forcing carriers to lower prices at the expense of margins.

The Sustainable Side of Property Insurance

Hurricanes Helene and Milton reminded us that the enjoyment of physical property should not be taken for granted: insurance seems like a useless expense until you really need it.

The table below highlights how insurance contributes to the United Nations’ Sustainable Development Goals (SDG).

How Insurance Keeps You Covered

Property insurers are the first line of defense that provide coverage for property damage. To make sure they have enough money when large-scale events occur, their actuaries conservatively calculate the required funds necessary in case of an event and regulators put rules in place for them to hold sufficient capital to support the policies they have issued. They use risk transfer techniques like reinsurance, which takes on a portion of financial risk of policies, generally the worst part, for a fee. They use it to protect against the worst events thereby reducing their capital requirements. This allows them to issue more policies with the same capital and grow their business from their direct contact with clients.

For their part, reinsurers take on the financial effects of the worst events and reinsurers also need to be well-capitalized. Reinsurers’ primary risk management tool is to diversify across insurers. But like insurers, they need to transfer risk to grow. Their tools to further spread their downside risk are catastrophe bonds and retrocession, also known as ‘the reinsurance for reinsurers” which generally comes from other reinsurers looking to diversify their exposure. Catastrophe bonds are standardized contracts issued by reinsurers in financial markets; investors get their capital plus interest at the end of the term if no catastrophic event occurs, as defined in the bond document. But, if something bad happens, they get an amount that is inversely proportional to the extent of the damage which can eliminate all of the expected interest payment and also eat in the capital they invested. In essence, the reinsurers get money up front and the investor takes on the risk of a bad event like a hurricane. All of those lines of defense are critical for the property insurance industry to continue to provide their service to property owners.

The picture below simplistically depicts how property insurance operates starting from the coverage of the property to who ultimately bears the risk to the property. At the property level, the property is insured but there is a deductible and some exceptions that are not insured, so the owner bears some of the risk and the client-facing insurer takes the rest. The client-facing insurer unloads the downside portion of its exposure to reinsurance which unloads the downside portion of its exposure to retrocession or insurance-linked securities.

When Insurers Can No Longer Provide Affordable Coverage

Population size and property values in risk-prone areas have exploded from a combination of older people looking for clement weather and easy access to credit. Insurers can no longer provide coverage at affordable prices in certain regions and governments have stepped in to complement or replace the private sector. The table below highlights places where government has had to step in. It may seem weird that taxpayer money goes to insure new multi-million dollar beach front properties in a high risk-zone such as Florida, but it is a reality. Like most insurance coverage, government-backed schemes use reinsurance as a risk mitigation tool.

Reinsurance to the Rescue

Property reinsurance requires sophisticated modeling and risk management, but it is a relatively simple business from a profitability standpoint: premiums plus investment income fewer claims and expenses determine profitability. The chart below shows the stock performance of a reinsurer index compared to an index of insurance-linked securities; there is a very high correlation between the two. From 2010 to 2017, both were going up, then they based for 5 years during a period of weak pricing power while claims increased. Since the pandemic, both insurers and reinsurers have had solid price performance.

To illustrate further the cyclical nature of the industry, the chart below highlights the insurance-linked securities index, which is a proxy for the profitability of the industry on a year-on-year basis and the property renewal rate index which shows the pricing power of the industry. Pricing power weakens when the industry is most profitable: past performance attracts more capital and this new capital tries to gain new business with lower prices which puts pressure on prices across the industry. As we can see on the chart, renewal rates were at their weakest in 2018 after seven years of strong profitability. A few years of poor profitability from 2018 to 2021, exacerbated by high inflation, resulted in extremely strong pricing power and much better profitability in the past few years.  

Compare insurance, reinsurance and the S&P 500 Index, reinsurance has been one of the few subsectors that have nearly matched the strong performance of the S&P 500. We can also see a significant fall in price at the start of the pandemic for reinsurers because they also cover extreme mortality events on top of property insurance. The risk for reinsurers at the onset of the pandemic was excess mortality from COVID which turned out to be less than originally feared. During the pandemic, reinsurers’ stock price fell much more than insurers when confronted with a potentially large event because they take on the extreme downside risk.

Insurance in a Changing Climate

The growing frequency and severity of climate-related events, such as floods, wildfires, hurricanes, and other natural disasters, has forced insurers to reevaluate their business models and adapt to manage rising risks and ensure long-term sustainability. Some of the techniques involved in doing this include:  

On the regulatory side, many jurisdictions are imposing stricter environmental and climate-related disclosures that insurers have to deal with.

An Overview of Key Reinsurance Companies

For the purpose of this note, we look at reinsurers with significant portions of their business in the Property and Casualty (P&C) segment. We concentrate our efforts on six public companies with more than 30% of their revenues originating from P&C reinsurance. Renaissance Re is the purest play while Scor has the lowest exposure.

Reinsurance Leaders

In general, reinsurers have improved their financial performance: strong pricing power and decent claim experiences have been the drivers. Nonetheless, as the price chart below highlights, there are discrepancies amongst the companies. Arch Capital has rewarded its shareholders the best and Scor, has performed the worst.

There are a few important reasons behind the diverging performance of these companies, including growth, risk management, claims experience, expense control and balance sheet management. The table below highlights how each company has performed along these vectors.

To further illustrate the gap in financial performance between companies, the chart below highlights the return on tangible equity for each company. There is a strong link between this measure and stock performance. SCOR is at the bottom just like its stock performance.

It is increasingly likely that you or someone you know has participated in a dry month, going alcohol-free. You may also have noticed more non-alcoholic options appearing on restaurant menus or at your local liquor store. Beyond the anecdotal, there is growing evidence of a decline in alcohol consumption. Changing attitudes towards drinking present some positives: reduced alcohol intake is associated with better health which can lower healthcare costs.

None of this has been overlooked by investors: with few exceptions, alcohol stocks have sold off solidly over the past several months.  

 In today’s note, we explore opportunities to underweight and/or short companies in an industry that is primed for overhaul.

 

Troubled Waters: The Challenges for the Alcoholic Beverage Industry

In developed nations, drinking has long been a part of the cultural fabric. However, younger generations are scaling back.

Within a decade, the share of American college students that abstain from drinking alcohol increased from 20% to 28%. In the U.S., only 60% of those aged 18 to 34 drink alcohol, compared to 70% in those aged 35 to 54 (see chart).

It was a long-held view that alcohol in moderation was not dangerous to health, and in some instances even heart healthy. This too is changing, as a growing body of research shows links with inclined risk of cancer. Nearly 20 years ago, a U.S. survey showed 25% of respondents perceived drinking in moderation as good for health. That has since declined to a low of 8%. In 2026, Ireland will become the first country to include cancer warnings on the labels of alcoholic beverages, similar to what is done for cigarettes. The tactic is also under consideration by other nations; broad adoption could have important consequences for the industry.

Furthermore, there may be options beyond sheer willpower to cut back on booze. One recent study suggests that semaglutide (weight loss drugs) could assist individuals in drinking less. Greater access to these drugs could have repercussions beyond snacks and fast food (please see our note, You Can Have Your Cake and Eat It Too, November 16, 2023), especially if deployed as a treatment for alcohol abuse.

Finally, the budding structural decline in alcohol consumption is not just a developed economy phenomenon. Although the picture is not uniform across developing economies, data from the World Health Organization (WHO) shows that annual per capita alcohol consumption is declining in every region of the world. Of course, developing countries with very high population growth rates can still be interesting markets for some alcohol producers, because even if individual consumers less, the consumer base may still grow. However, investors need to be cognizant that the trend away from alcohol is globally entrenched and it is not at all clear that EM consumption will offset the decline elsewhere in the world.

 

Moreover, even if EM alcohol consumption is robust, it is hardly clear that the incumbents, i.e. multinationals with strong brand recognition, will benefit. The alcohol industry is not immune to an increasingly hostile global trade backdrop. European spirit-makers are currently in the crosshairs of Chinese policymakers in revenge for new European tariffs on Chinese EVs. Spirit-makers are especially vulnerable to this development, since they tend to be more exposed to sales in these countries relative to the major developed market beer producers.

Faced with this decline in demand for their products, alcohol producers have struggled to raise prices relative to other consumer prices. The chart below shows the evolution of U.S. consumer price inflation; from 2000 to 2015, alcohol prices always rose in line or faster than overall prices. However, since 2015, alcohol price inflation has failed to keep pace.  

 

Material Risks for the Alcoholic Beverage Industry

Using a double materiality framework, we classify alcoholic beverage products as having negative impact, substantiated by health issues and problems of dependence. Operationally, we align our analysis with the SASB materiality framework and see ingredient sourcing and water management as the most material environmental risks faced by producers. The availability and cost of grains and other agricultural inputs will be impacted by climate change and water is also indispensable to the production of alcoholic beverages. Even large scale brewers like Anheuser-Busch and Heineken, who are recognized for their efficiency need roughly 3 litres of water to produce 1 litre of beer.

Spirit-makers are overall less water intensive than beer producers and have significantly less total water usage. However, there is a wide range in water efficiency across major distilleries, with Remy Cointreau being most efficient and Campari Group (Davide-Campari-Milano) the laggard. Conversely, there is little distinction between the major beer producers in terms of water efficiency.

Note that in our list of public companies, Treasury Wine Estates has the poorest water efficiency. This is not surprising since growing grapes is very water intensive. The company’s larger water footprint reflects the cultivation of ingredients while most distillers and brewers purchase raw ingredients.

Constellation Brands generates 15% of revenues from wine and 82% from beer. Along with Treasury Wine Estates, it is the only other company from our list without a water efficiency target – a concerning oversight given these two companies operate in water-stressed areas like Australia, California and Mexico. Brewers have a lower margin business, with water being a major input cost – this makes the lack of a water efficiency goal a significant oversight on the part of Constellation Brands.

With regards to ESG scores, Constellation Brands stands out as a laggard with the lowest overall rank and being at the 50th percentile relative to its industry. There is little distinction between the other beermakers, with all companies within the top quintile. The spirit-makers exhibit a greater divergence: Diageo and Pernod Ricard take top ranks (even higher than the brewers), while Campari Group, Brown Forman and Becle lag. We expect beer companies will have an easier time adapting to seltzers or non-alcoholic drinks than their distiller counterparts; we therefore focus the remainder of our analysis on distillers and Constellation Brands.

 

 Identifying Short Candidates

Having identified short candidates based on material sustainability risks, we now assess according to three factors that influence the price of distillery stocks: brand value, potential for acquisition, and overall efficiency of capital allocation and operations.

Brand value: Structural changes in consumer preferences means that there is more uncertainty about whether brands can hold their value. Almost all of the major distillery companies have seen an erosion in the value of their intangible assets as a percentage of total assets over the past five years (by 5% on average for 5 out of the 7 companies); there are no obvious catalysts for a reversal in this trend.

Acquisitions: One way to address a stagnating demand backdrop is through acquisition. Since building new brands is capital intensive and time consuming, acquiring established brands can fast track growth. We expect consolidation attempts will continue, although much has already occurred; all of the major distillery brands have been involved in acquisitions over the past ten years and each company already operates between 8 and 26 main brands. Given this backdrop, the size and pace of deals may be underwhelming going forward and implies that the impact on the incremental value will be smaller.

Capital Allocation and Operational Efficiency: The other way to create value is to improve the efficiency of capital allocation and operations. We use the invested capital turnover to evaluate capital allocation efficiency as it measures the amount of sales per unit of invested capital. All of the major alcohol companies we analysed exhibit declining investment capital turnover in the past five years with Becle and Remy Cointreau showing the worst efficiency in this regard.

For operational efficiency, we examine profit per unit of revenue via the net operating profit after tax NOPAT) margin. Among these companies, Remy Cointreau and Constellation Brands show some improvement in their operational efficiency over the years while Brown-Forman, Becle and David Campari-Milano worsened. This aligns with our sustainability analysis above; as companies that are better managing material risks like water have better operational results.

Plotting these two metrics informs on the return on invested capital (ROIC). In the chart below, the companies appearing in the top right have a relatively high ROIC, suggestive of a competitive advantage in cost leadership and product differentiation whereas Becle and Remy Cointreau have a weaker ROIC, meaning they are more at risk of losing market share. This is evidenced in their current stock valuations.

 

Shorting the Laggards: Timing Is Everything

Many of the major distillery stock prices have already been beaten down: along with structural headwinds identified in this note, producers have been faced with supply chain issues, a post-COVID slowdown in sales, and higher input cost pressure.

As a result, many companies are now trading at relatively cheap valuations (for example Becle, Brown-Forman and Remy Cointreau now have P/Es in the low 20s compared to over 30 at the start of the year).

We have high conviction that the structural backdrop for distillery stocks will continue to erode, thus making fertile ground for short opportunities in the long-term. However, in the short term, the current risk/reward profile suggests investors should wait for a bounce before getting involved.

In our last macro update (March 27, 2024), we had argued that the rate backdrop had become relatively benign for equity markets and that investors should begin to reflect on sector implications of a potential Trump presidency. The interest rate environment was indeed calm over the past six months: the Fed is on the cusp of its first interest rate reduction in over four years and has managed to stay very aligned with financial market participants’ expectations. However, whether the Fed can continue to deliver the rate cuts that are expected after September still depends on inflation.   While there is more and more indication of lagging economic activity (in particular, we highlight below the impact of worsening credit conditions for consumers), the Fed can only provide stimulus if progress toward lowering inflation to 2% is sufficient. The most recent data was not encouraging in this regard; August data shows that progress at bringing down core CPI has stalled and prices continued to rise over the summer at over 3% annually.

On this basis, it’s hard to see how the Fed moves to a more accommodative stance barring a severe weakening (contraction) in economic growth. The bottom line is that contrary to the past six months when the Fed and market expectations of interest rate policy have been well aligned, odds are rising that policymakers will be unable to deliver on market expectations for rate cuts of 75 – 150 bps by year end.

Meanwhile, judging by the election betting markets  after Tuesday’s Presidential debate, the likelihood is increasing for a Democratic win, reducing the allure of the “Trump trade”  (i.e. overweight positions in USD, prisons, banks and oil companies).

From a sustainability perspective, the debate bolstered our suspicion that Harris is unlikely to make bold moves regarding major issues like climate change, climate adaptation and health care. Climate change was nary discussed, except to underscore that Harris would not ban fracking. On healthcare, she promised to “strengthen” Obamacare and to keep in place the Biden’s administration $2,000 cap on out-of-pocket prescription drug costs, which is slated to take effect for Medicare enrollees in 2025.

In terms of overall government spending, the debate confirmed our view that irrespective of the election result, U.S. fiscal spending will be neither headwind nor tailwind for financial markets in Q4 2024 and 2025.

The chart below shows that in the U.S., the fiscal policy contribution to real GDP growth will become roughly neutral in the fourth quarter of 2024, and be mildly negative throughout 2025. The Brookings Institute’s projection shown in the chart assumes an extension of the provisions of the 2017 Tax Cuts and Jobs Act that are set to expire at the end of 2025, an assumption that we find most plausible. Trump has stated that if he wins, the tax cuts will of course be extended, while Harris pledges to re-distribute the fiscal burden among tax brackets. In both cases, overall tax revenues will not look very different.

Overall, the conclusions from our recent note covering the U.S. election “US Election Color Wheel: Spotting the Green in the Blue vs. Red Landscape” still hold:  Harris’ approach of an “all of the above” domestic energy policy (including fracking) is unlikely to tarnish the allure of investing in regulated carbon markets. Meanwhile, sectors like engineering services will prove resilient regardless of who makes it to the White House since it’s now common lore that the U.S. needs improved infrastructure as well as more (cheap and clean) energy.

What else should thematic sustainability investors keep an eye on in the months ahead? Consumer health and a potential defensive rotation top our list.

Consumer Check- Up

Financial market pundits are ratcheting up expectations for a recession, which typically means bear market. But for the U.S. to slide into recession, it will take a much bigger crack in consumer spending.

With excess savings now largely been worked off, credit cards and other forms of consumer financing have also become more heavily tapped. So much so that lending institutions are beginning to ring a warning bell. Comments from consumer finance company Ally Financial earlier this week – and the company’s stock price reaction (-19%) – particularly struck us. The CFO articulated a view whereby borrowers have been struggling with the cost of living, and now are also faced with a deteriorating employment backdrop; late-stage loan delinquencies are rising and there is a necessity to shore up reserves.

To be sure, the Fed’s highly anticipated September interest rate cut is designed to alleviate building stressors in the consumer sector and interest rates at the long end have already declined somewhat. Nonetheless, consumers are less sanguine about their economic prospects and it is rational that this translates into a pullback in discretionary spending.

So far, 2024 has already seen a modest outperformance of consumer staples stocks relative to consumer discretionary names when looking at the overall S&P sectors. This is true even when omitting index heavyweights Tesla and Amazon from the discretionary universe.  Given the discussion above, we expect that staples will continue to outperform discretionary stocks as consumers pull back spending.

Admittedly, however, sustainability concerns have not been a factor in driving the outperformance of staples: since January, SMS’ universe of consumer staples sustainability winners (primarily food companies) has only performed on par with our universe of consumer discretionary sustainability losers. Much of the disappointing result is coming from strong price appreciation of single names in our consumer discretionary short universe: despite sub-par ESG and sustainability records, cost-conscious consumers have not shied away from fast-fashion (Abercrombie & Fitch is up 67% YTD) and fast food (Wingstop and Brinker International are up 61% and 48%, respectively). Although this underscores the need for strong stock selection, as we wrote in a recent note “Consumers Bite Off More Than They Can Chew: An Outlook for the Restaurant Industry”, the current economic environment nonetheless implies less restaurants (discretionary) and more food at home (staples). We expect that the outperformance of staples will continue and stronger sustainability candidates offering good value will be propelled higher.

Defensive Rotation?

The decent performance of consumer staples recently is of course also thanks to an important rotation out of tech stocks that began this summer. We continue to believe that risks favor more air coming out of still sky-high valuations in AI-hyped stocks and it’s not just staples that will benefit. The health care sector helps form the backbone of diversified sustainability portfolios and current macro conditions are helpful for this sector.  

Overall, the health care sector displays defensive characteristics much like staples; it’s hard to cut back on medications and health care procedures even when times get tougher. It is worth noting that Harris acknowledged the ravages of the fentanyl crisis in the Presidential debate and that the NOPAIN Act (Non-Opioids Prevent Addiction in the Nation Act) is a popular, bipartisan legislative effort, aiming to reduce opioid dependence by expanding access to non-opioid pain management treatments. Starting in 2025 separate Medicare reimbursement for FDA-approved non-opioid therapies will be provided, particularly in outpatient surgical settings. Pharmaceutical companies such as Pacira BioSciences (PCRX US), Indivior (INDV LN), and Vertex Pharmaceuticals (VRTX US) are developing non-opioid alternatives, positioning themselves as promising investments.

With U.S. interest rates now on a downward trajectory – approximately 200 basis points of cuts are anticipated over the next 24 months – and electoral polls indicating a tight race between Donald Trump and Kamala Harris, today’s note revisits the performance of our sustainability themes during electoral periods. We also assess the economic and policy differences between the 2020 context and today and explore opportunities for re-entry into some of our favorite investment themes.

First, we examine the performance of seventeen of SMS’ sustainable investment themes three months before, and three months after the 2020 election. Recall that interest rates were near zero during this period due to COVID-19. Some themes, such as Human Capital (which includes edtech, up 68%), Tech Infrastructure, and Transition Materials (up 45%), performed exceptionally well, while others, like Alternative Energy, somewhat underperformed (up 5%) post-election – especially we consider that the S&P 500 was up by some 10 percentage points in the three months following the election. In our view, the performance of many of our themes was driven more by market momentum and close-to-zero interest rates than by any government policies discussed during the 2020 election.

As such, there was a clear rotation in and out of several sustainable investment themes following the 2020 election. This time around, investors should also be prepared for another election-based market shift – especially if we consider that market participants already penciled in a Trump victory - and discounted several sustainability plays. Now that a Harris victory is the cards, investors could re-ignite the kind of hype in themes such as renewables and energy transition we last witnessed in 2019-20.

A second consideration is to explore how the election could alter the fundamental trajectory of U.S. policymaking, which could also impact several of our investment themes. The table below outlines our expectations for what could stay the same versus what could change following the election - and identifies potential areas for surprise.

Given the table above, we suggest four sustainable investment ideas that take into account the current U.S. political and monetary backdrop: Shorting prisons, going long on carbon, engineering firms, and renewable energy.

Short Prisons

Private prisons remain a contentious theme in the U.S., with equity prices in the sector closely tracking electoral polls. While Kamala Harris would likely aim to shut down private prisons and prolong Biden’s policy on the matter, Donald Trump would probably expand their role in the U.S. carceral system. As Harris is currently leading Trump in the polls, prison stock prices have already receded. Companies such as GEO Group (GEO US) have already profited from stricter immigration control policies, including electronic surveillance through apps, which have boosted revenues for companies in the sector. One could expect such controls to be less infringing on immigrant rights should Harris win, likely capping prison stock prices.

From a valuation perspective, prison stock prices also seem stretched when considering their 12-month trailing P/E ratios – they are trading at a 50 percent premium compared to their 2020 levels. That said, as immigration remains an important electoral theme – and in a context where private prisons increasingly rely on immigration flows as a source of revenue - we recommend taking a smaller short position on this theme while continuing to monitor polls closely.

Long Carbon

One of the starkest wedge issues between Kamala Harris and Donald Trump is their stance on the environment and carbon. Kamala Harris, known for her prosecutorial background, did not hesitate to take on Big Oil and win a settlement for the people of California over environmental damage from climate-warming fossil fuel emissions. In contrast, Donald Trump advocates for minimal, if any, environmental regulations.

This divergence in views is evident in North American regulated carbon markets. December 2024 carbon futures have recently plummeted due to 1) the prospect of Trump winning the election (especially when he was leading in polls), 2) the politicization of carbon markets (the State of Washington has put the termination of its newly created carbon market on the November 5th ballot), and 3) retail investors feeling the pressure and cashing out of their positions.

That being said, current North American carbon auction pricing dynamics are approaching the government-set floor price of $24.04, which is 25% lower than the most recent auction price of $30.24. As a reminder, the floor price is set by WCI member governments to increase by 5% plus inflation every year. For an investor with a six-year time horizon, the floor price will be equivalent to the current price in 2030, even if inflation is 0% between now and then. Investors now have the chance to buy the equivalent of a convertible bond that will pay inflation between now and 2030 with a conversion price equivalent to the current price. If the price of carbon credits rises to last spring’s peak of $44, a return of almost 50% could be achieved. For public market access to this play, investors can purchase the KCCA ETF, which has dropped by about 25 percentage points since its February 2024 peak.

Furthermore, the foundations of the North American carbon market remain strong. New York State is contemplating the creation of its own market, which could potentially merge with the Western Climate Initiative, which include the main players in the market such as California and Québec. Additionally, current electricity demand trends in North America, particularly in California, suggest that the scarcity of emission rights could return soon amid a growth in production – including from non-renewable sources. This is currently our strongest conviction for a “Kamala trade.”


Long Renewable Energy

In a recent note, we recommended re-entering the renewables sector when and if interest rates began to decline (see our note “A Second Wind: What Peak Interest Rates Mean for Renewables” March 21, 2024). Now that approximately 200 basis points of rate cuts are priced in over the next 24 months, we are somewhat surprised that the sector hasn’t yet rebounded, especially in light of recent trends in energy demand in the U.S. In that, we think that the time to re-enter the renewables space is now.

While we don’t anticipate additional government funding à la Biden IRA for the sector just yet, overweighting the sector could makes sense if you think that Kamala will make it to the White House. Companies - developers and operators - that have demonstrated strong revenue growth these past years amid higher interest rates – such as Acciona and Hannon Armstrong – could strongly reprice positively in the coming months, even if they are already trading at high P/E ratios.

Long Engineering & Construction

Given that infrastructure spending is likely to persist regardless of who wins the White House, the Engineering Services sector looks promising, especially for companies with a strong presence in the United States. We place particular emphasis on those that have developed leading sustainability practices. Many of the companies listed below have integrated sustainability as a key feature of their practice, making them a natural fit for sustainability-focused portfolios as they are the builders of infrastructure of the future.

The sector has substantially outperformed the rest of the stock market since November 2020 and, to much surprise, has even proved resilient to the current higher interest rate environment. To this end, SMS’s Green Engineering Leaders Equal-Weighted Index has outperformed both the S&P and Nasdaq by nearly 100 percentage points since Biden was elected to the White House in 2020. Given both parties’ interest in improving infrastructure, we believe this trend will continue for the foreseeable future. Companies like Stantec and Arcadis stand out in this group for their sustainability features and relatively attractive valuations.

 

Macro: “A Tall Order for Restaurants”

At the start of the month, U.S. Employment data sent a shock wave through financial markets. There were fewer jobs created than was expected and the unemployment rate increased to its highest level since October 2021. And just yesterday, a significant downward revision of the number of jobs created in the 12 months leading up to March 2024 was announced. This trend does not bode well for discretionary spending like restaurants, especially when interest rates remain elevated.

Although subsequent data struck a more “goldilocks” tone, we still see reasons to believe that households will curtail spending at restaurants:

  1. Although overall inflation fell below the 3% mark for the first time in over three years, for food prices, the cost of dining out is significantly outpacing the cost of eating at home. To be sure, restaurant food inflation can be taken as a sign that restaurants have been able to pass on higher input costs to consumer. However, as the relative cost of dining out vs dining in become stretched, we expect that more consumers will turn budget-conscious and opt for eating at home.

  2. The latest retail sales may have surprised to the upside, but a closer look at spend on bar and restaurants shows that spending on food away from home is starting to plateau since its post-pandemic boom (see chart below). On a monthly basis, food services and bar sales increased 0.3% while grocery store sales rose by 1% reflecting the swap to dining in as mentioned above. These observations are especially noteworthy given that retail sales data does not adjust for inflation which remains elevated for dining out. Furthermore, sales data for other discretionary areas, like leisure and apparel, were weaker compared to the previous month.

At Sustainable Market Strategies, we are more inclined to short the restaurant industry concerns over nutritional content and quality of employment. This is fitting for the current economic backdrop. However, we also remain vigilant for potential buying opportunities if value has been created. The remainder of today’s note focuses on American publicly traded restaurant companies, as there are virtually no comparable European listed options, and companies listed in Asia are further removed from U.S. economic and consumer data.

Corporate Responsibility in Restaurants: The Long and Short of It

 The biggest issue with the restaurant industry is the poor nutritional value offered to customers. In our list of publicly traded American restaurant companies with over 1 billion USD in market cap, most fall into the fast-food category, also known as limited-service restaurants. Sure, everyone loves a treat and the convenience of take out, but the widespread availability of cheap, high calorie meals is problematic: the expansion of fast-food chains has long been associated with rising obesity.

Unfortunately, full-services restaurants, offering sit down meals served by wait staff, don’t fare much better on the nutrition front. Two studies from 2018 showed that meals at full-service restaurants often contain even more calories than the meals at fast-food chains. None of the companies in these two segments (limited and full service) stand out as having a more health-focused brand, we therefore do not consider them for long positions.

The last two decades saw the emergence of a third restaurant category: Fast casual. These restaurants offer the same quick convenience, often in a more upscale dining experience. Fast casual restaurants tend to have more limited menus with basic ingredients, benefitting from simplified supply chains. This category is where we see the greatest potential for long candidates. Not all fast casuals are created equal: some, but by no means all, emphasize healthier menus. We consider what they serve, average calorie content and branding (self-proclaimed mission or menu description). Our analysis identifies Sweetgreen, Chipotle and Cava as candidates for long positions given their lower in calorie and higher in vegetables menus.

According to the Sustainability Accounting Standards Board (SASB), another material consideration for the restaurant industry is their role as employers. Restaurants are major employers in the U.S., but these jobs tend to offer low pay, few benefits and poor working conditions. None of the companies we reviewed had a CSRHub Employment Score rank within the top 20%. Though none qualify as high-quality employers, we deem companies with scores below the 40th percentile as particularly underperforming. The companies are ordered by their Employment score rank in the table below.

Finally, we assess energy, waste and water metrics (also key topics identified by SASB). The extensive number of restaurant locations makes for a significant environmental footprint. Food safety and Supply Chain Management are also flagged as key issues by SASB. Food safety is difficult to assess beyond health records and past controversies. For supply chain management, we give a leg up to the fast casual restaurants given their simplified menus. The table below presents our findings on the three categories of restaurants.

For the fast casual segment, we retain only Chipotle on the long side. Despite better nutrition in their menus, Cava Group and Sweetgreen (whose labor score is notable) do not have sufficient disclosures to retain as long opportunities. Wingstop is kept as a short candidate given its weaker labor score and lack of reporting on environmental factors. Recall that limited and full-service restaurants are only considered from the short angle given their poor nutritional value. Three shorts are identified in the full-service segment: Darden Restaurants, Texas Roadhouse and Bloomin Brands; and two in the limited-service segment: Domino’s Pizza and Krispy Kreme. These companies are identified as short candidates due to their poor labor scores and weak disclosures.

Various Business Models Drive Diverging Stock Results

Since the pandemic reopening, fast casual restaurants stock prices are the only segment that have outperformed the SP500. The performance or full-service restaurants is relatively flat and limited-service restaurants have seen price declines.

This can be attributed to the different business model characteristics of each of the restaurant segments. Fast casual and full-service restaurants have higher price points and therefore tend to have higher-income patrons that are better able to weather the rising inflation over this period. Up until 2024, the performance of these two segments was mostly aligned. But fast casual has two advantages over full service: health (higher quality menus) and convenience. Customers of these restaurants are seeking the convenience of a fast-food place but willing to pay more for a better quality or more specialized menu.

Most of the short candidates we identified have seen sales growth decline in the first half of 2024 compared to last year. Full-service restaurants have seen sales growth reduce the most (see chart below). Wingstop, in the fast casual segment, has also had waning sales growth, but still remains well above restaurants in the other categories (though this cannot be attributed to customers seeking healthier options and is likelier more the result of expansion). Domino’s is the exception, and may be explained by consumers trading down from fast casual or other more expensive pizza chains. Within the fast-food category, the last two quarters saw sales growth decline for both Starbucks (-0.6%) and Papa John’s (-1.3%) while it remained positive - around 7% - for Krispy Kreme and Domino’s.

In the limited-service (fast food) category, restaurants that are able to offer the best deals will be favored by consumers. With their higher margins, fast food giants like McDonald’s (33% net margin) and Yum! (owner of Taco Bell, KFC and Pizza Hut, net margin of 23%) will have the greatest capacity to offer discounts, cutting prices on some items while maintaining positive margins.

Still, if rates remain elevated and unemployment continues to rise, we expect a further decline across the board for restaurants. It is noteworthy that Krispy Kreme, Domino’s and Wingstop have the highest betas. Chipotle, a long candidate (though too richly valued today), also has a relatively higher beta.

In a world shrouded in uncertainty—marked by elections, climate change, and the specter of new conflicts—there is a clear consensus: deglobalization is taking hold. Consider the upcoming U.S. elections. Although Kamala Harris has yet to reveal her economic platform, her predecessor Joe Biden shared one crucial stance with Donald Trump: a focus on strengthening the national economic base, even at the expense of deepening international ties. These developments matter for all investors and in particular have ramifications for investors concerned with sustainability: moving production from jurisdictions that have varying degrees of control and/or oversight regarding environmental and social considerations will change the course of progress in these areas. In today’s note, we evaluate how strong the deglobalization trend really is and what this means for investors.

Has Deglobalization Really Increased Since COVID-19?

Global trade expanded rapidly in the 1990s and 2000s, driven by advancements in technology, China’s entrance into the World Trade Organization and the resultant rise of multinational corporations. The idea of deglobalization, however, started gaining momentum during the global financial crisis in 2008. Some governments, in an attempt to boost domestic production and employment, began prioritizing protectionist measures, imposing restrictions on the free movement of trade and investment across borders. Since then, global trade patterns have shifted. Overall, the growth of global imports as a percentage of GDP, which had steadily increased for decades, began to plateau around 2008 and has stalled ever since (see the chart below). In other words, global trade is no longer growing.  

Following the 2008 crisis, the COVID-19 pandemic served to expose weak links in global supply chains. The urgent need for critical supplies at that time, such as masks and medical equipment, revealed the risks of over-reliance on distant suppliers, particularly from China. In the U.S. and elsewhere, the episode created popular support for inward-looking policies. For example, the U.S.’ Biden administration has pushed for reshoring through initiatives like the Inflation Reduction Act (IRA) and CHIPS Act.

However, true deglobalization, when trade as a share of total economic activity begins to shrink, is not yet occurring; imports as a share of GDP have stalled but are not yet falling. It is true that the underlying conditions for sustaining openness - domestic social consensus in its favor and a convergence of global monetary, legal and regulatory regimes- are becoming increasingly fragile (please see our note “Global Supply and Its Chains: From Efficient Bounty to Complex Scarcity?”, March 3, 2022). But instead of driving a decline in overall trade, dramatic shifts in trading partners (i.e. import source) are occurring. In other words, it is not the level of trade that has fallen since COVID-19, but rather who-trades-with-who that has changed.

The following chart illustrates these changes from a U.S. perspective. From 2016 to 2023, Mexico, Vietnam, and India have gained more of the U.S. import share, while China's share has dropped. Similar patterns are no doubt occurring in the euro area and elsewhere, as various government policies and incentives drive businesses to diversify their supply chains and reduce their reliance on any single nation. Importantly for investors, these shifts have the potential to create opportunities in companies that are benefiting either from a diversification of supply chains and near-shoring or greater re-shoring.

Supply Chain Diversification and Near-Shoring: Opportunities in Mexico, Vietnam and India

As the chart above highlights, Mexico, Vietnam and India have already become the benefactors of U.S. trade policy aimed at boosting supply chain resilience and reduced dependency on China:   

This year, the U.S. introduced the Biosecure Act to reduce dependency on Chinese pharmaceutical imports, and as a result, India's contract manufacturing sector is expected to double in the next three years, further solidifying its position as a key player. In terms of headwinds, safety concerns have prompted increased FDA inspections and scrutiny over the quality of India’s drug manufacturing. Ergo, investors must be vigilant about the sustainability practices when considering Indian pharmaceutical companies, as some have faced recalls and quality control issues in the past.

The following charts highlight the characteristics of select Indian pharmaceutical firms, each with the majority of their revenue derived from Europe and North America, and having no major controversies linked to their products. These companies are poised to benefit from further nearshoring trends. Of the four companies highlighted, Neuland is the most likely to benefit from the U.S. Biosecure Act due to the company’s role in supporting biotechnology and pharmaceutical companies. The stock has already enjoyed a massive recent run-up, so timing an entry will be key.

Re-shoring Winners: Select U.S. Industrials in the Pole Position

Although deglobalization so far has been mostly about shifting the country of origin of supplies rather than repatriating production, there is nonetheless some evidence that manufacturing is returning to some countries like the U.S. Sustainable Market Strategies’ readers should be familiar with the chart below that shows construction of manufacturing facilities in the U.S. is in a multi-decade breakout.

It is no surprise that the breakout in construction spending on manufacturing corresponds to a significant outperformance phase for companies that are benefiting from this demand. Indeed, the chart below shows that the SMS U.S. deglobe industrial index, when compared to the overall U.S. and global industrial indices, has outperformed. Our index is a sub-selection of U.S. industrial companies that generate most of their revenues domestically.

To be sure, industrial companies tend to be pro-cyclical plays, i.e. higher beta, outperforming when economic activity is in an upswing, and underperforming when a recession is in play. Interestingly, we can rule out choosing higher beta names as the reason for the outperformance of our U.S.equal-weighted deglobe universe: since the average beta in our index is about the same as the beta of both overall global and U.S. industrial benchmarks.

In other words, industrial companies that are most likely involved in the buildout of factories and facilities needed in reshoring are seeing their stock price react positively to deglobalization tailwinds. This is particularly reassuring given that the market consensus is now building in higher odds of a recession over the next twelve months.

Interestingly, this phenomenon – the outperformance of industrial companies most exposed to the building out of domestic manufacturing facilities – is only occurring in the U.S. We repeat the exercise for European companies and note that there is no stock price discrepancy between “deglobe exposed” and broader baskets of euro area industrial companies.

The investment community usually has strong views about its role in solving environmental and social issues. Ask any investment professional how they approach the climate crisis, and they will enthusiastically discuss their investments in renewables and other clean technology disruptive strategies. Now ask them about their strategy to address the opioid crisis. In our experience, the opioid epidemic is one of the most critical societal issues that remains largely ignored by the financial community.

Healthcare is often perceived as a straightforward sustainability or impact investment due to its inherent focus on improving lives and promoting well-being. However, the sector is not devoid of controversies and egregious behaviors that can undermine its positive impact. Our previous research on insulin prices (see Basic Instinct: The Insulin Profit Machine, September 22, 2022) highlighted significant ethical concerns, demonstrating how certain practices can lead to affordability issues and hinder access to essential medications. For investors, it is crucial to go beyond the surface and conduct thorough due diligence to identify and mitigate such risks.

In this week’s note, we will explore the financial implications of the opioid crisis affecting millions in the United States and beyond.

 

The Context of a Crisis

While the opioid crisis is a global issue, the United States is particularly affected by this epidemic.

Unfortunately, the opioid crisis in the United States continues to escalate, with the number of deaths increasing year after year. Despite ongoing efforts to combat the epidemic, the situation remains dire and shows no signs of improvement.

Opioids have been the leading cause of death for individuals aged 18 to 45 since 2019, claiming 200 American lives daily. This epidemic severely impacts the American economy, with estimates suggesting it accounts for 43% of the decline in men’s labor force participation and 25% for women. States with lower median incomes and higher unemployment rates, such as West Virginia, Kentucky, and Alabama, have the highest opioid dispensing rates, highlighting a strong link between economic despair and opioid dependency.

US politicians on both sides have shown a desire to connect more closely with rural America, so it is not surprising to see “opioid epidemic” being increasingly mentioned in their respective speeches.

In late 2022, a significant demonstration of bipartisanship occurred when congressmen from both parties approved the NOPAIN Act (Non-Opioids Prevent Addiction in the Nation Act). This legislation aims to reduce reliance on opioid prescriptions by expanding access to non-opioid pain management treatments. Starting in 2025 separate Medicare reimbursement for FDA-approved non-opioid therapies will be provided, particularly in outpatient surgical settings. This legislative effort underscores a broader recognition that addressing the opioid crisis requires comprehensive strategies, including holding various sectors accountable.

The Offenders

Although a large part of the blame must go to pharmaceutical companies that designed, manufactured, and promoted these products, other parts of the healthcare sector, such as distributors, retailers, pharmacies, and insurers, also share in the responsibility. The legal troubles for a suite of healthcare companies began a decade ago when state and municipal governments across the United States launched thousands of investigations. The specific crimes and subsequent settlement amounts varied depending on their roles in the opioid crisis.

For many, the most notorious offender in the opioid crisis is Purdue Pharma and its owners, the Sackler family. They will forever be remembered as the creators of OxyContin, a drug that was deceptively marketed as having a low risk of addiction despite its potent similarity to heroin. Purdue Pharma ultimately declared bankruptcy but initially agreed to pay $6 billion for its pivotal role in igniting the opioid epidemic. Originally, the settlement shielded the Sackler family from future civil claims though they had withdrawn billions from the company before the bankruptcy. However, in a surprising turn of events last month, the Supreme Court rejected this part of the settlement, potentially reopening the door to thousands of lawsuits against the Sackler family.

More pertinent for current equity investors is what role publicly-listed healthcare companies played and how they responded to accusations. Investors' decisions to include or exclude these companies from their portfolios will vary based on individual tolerance and justification.

The Opioid Cartel: Who is Responsible for What

For sustainability-minded investors, it is crucial to seek assurance that companies will behave differently if a similar situation arises. The opioid crisis highlighted failures across the entire healthcare supply chain:

The failures on multiple levels underscore the importance of having accountability and robust ethical practices within the healthcare industry to prevent future crises.

The "Responsible Investment Theory" suggests that companies engaged in controversial behaviors should suffer financial or reputational damage. However, with a few exceptions such as the bankruptcies of Purdue Pharma, Insys Therapeutics, and Mallinckrodt, many larger players have largely weathered the storm. Companies like Johnson & Johnson and CVS have faced the opioid settlements as one of many challenges in recent years, indicating that the impact on their financial health and reputations has been somewhat limited compared to their overall market presence and diversified operations.

Looking ahead: the investment opportunity

The upcoming implementation of the NOPAIN Act could mark a significant inflection point for investors seeking to address the opioid crisis through strategic capital allocation. By boosting non-opioid alternatives, the Act opens new investment avenues for impact-minded investors.

The investment opportunity falls into two main categories: companies providing pharmaceutical solutions to current opioid dependence, and companies developing non-opioid alternatives for pain management.

For the first category, we focus on companies offering overdose reversal medications like naloxone hydrochloride nasal sprays, and other treatments to prevent relapse in opioid-dependent patients:

In the realm of developing alternative non-opioid pain management medications, one might expect a crowded field given the significant market potential for effective pain relief that avoids addiction risks. However, pain management research is notoriously challenging and often leads to dead ends. After years of arduous clinical trials and numerous unsuccessful attempts by Big Pharma to discover new mechanisms for pain treatment, there is finally a glimmer of hope.

In late July, the FDA granted Vertex Pharmaceuticals (VRTX US) Priority Review for its New Drug Application for suzetrigine, an investigational oral non-opioid treatment for moderate to severe acute pain. The FDA’s decision is expected by January 30, 2025. If approved, suzetrigine could become the first new class of drug approved for acute pain in over 20 years! Unlike opioid-based painkillers, suzetrigine treats pain without entering the brain, thus avoiding the addiction potential that opioids present. This new class of medication will undoubtedly be more expensive than traditional opioid drugs, but the NOPAIN Act addresses this issue by providing higher reimbursement rates for non-opioid drugs.

Another company poised to benefit significantly from the implementation of the NOPAIN Act is Pacira BioSciences (PCRX US). Pacira produces EXPAREL®, a non-opioid local analgesic used for postsurgical pain management. The NOPAIN Act's reimbursement changes are expected to significantly increase the utilization of EXPAREL® in surgical settings, enhancing its market penetration and impact.

These developments underscore the recent breakthroughs creating promising opportunities in non-opioid pain management. These drugs present substantial potential for positive impacts on both public health and investment returns. Screening for valuation and market capitalization, a strategic combination of Vertex Pharmaceuticals (VRTX US), Pacira BioSciences (PCRX US), and Indivior (INDV LN) looks like an attractive investment approach to capitalize on the implementation of the NOPAIN Act in 2025.

Investing in these companies not only aligns with emerging healthcare trends but also supports the transition towards safer, non-addictive pain management solutions.

 

You probably remember Miss Materiality from our December 2022 note: Miss Materiality’s Night Out: A Lesson in Consumer Choice and our August 2023 note: Miss Materiality’s Summer Vacation. She is back for a third year, this time, at the grocery store. In 2022, right after the pandemic, she just wanted to go out. Last year, she wanted to get away. This year, she is concerned about meeting her basic needs because the reality of higher and more volatile food prices is becoming a greater preoccupation for her.

Miss Materiality has become more cost-conscious this year and this is translating to how she spends on food she cooks at home.

On her list, she has the basics that are difficult to replace, things like olive oil, milk and sugar. She needs protein: salmon, eggs, tofu and some meat and she cannot live without coffee, orange juice, bananas and chocolate. Recent sticker shock for some of these items leaves her curious about the evolution of prices over the past five years.

As can be seen from the graph below, the overall cost of her basic foodstuffs has increased, with olive oil leading the way higher, albeit milk has reverted to pre-pandemic price levels.

 

Researching the salient points for each food item (see table below), Miss Materiality notices a common theme: the impact of the weather. Olive oil and sugar price inflation is the result of supply disruptions from droughts.

For proteins, the trend toward higher prices has been volatile and she was happy to see recent price drops after massive run-ups in basic ingredients like eggs.

Traditional supply and demand factors have been at play in proteins; except for eggs where the H5N1 disease created a shortage in 2023 that is still not completely resolved.

 

Miss Materiality noticed large price moves for the things she loves most. The cost of cocoa is a relatively small portion of the price of chocolate bars but with cocoa price shooting up in recent years, chocolate bars have followed suit with, higher prices per gram.

From a nutrients and calorie perspective, her other favorite snack, bananas, are cheaper than other fruits and have remained so for many years. Miss Materiality was wondering why and she found that bananas are produced in many countries. India, China and Indonesia are the top 3 producers but they have large populations to feed. The top exporters are in Latin America: Ecuador, Costa Rica, Colombia and Guatemala. Other reasons for the low prices of bananas are the fact they are picked green and ripen during their transportation, the trees are perennials and there is a strong global system for bananas. In other words, diverse geographic crop location and ease of transport makes bananas one crop that is relatively insulated from many of the major threats of global food supply disruption. That’s a good thing for Miss Materiality!

Just like for the basics, Miss Materiality realized that the weather played a significant role in the prices of indulgence items. For some of her other favorites like coffee and orange juice, weather and diseases – both directly linked to climate change – are creating episodic shortages that drive prices higher.

 

These price surges underscore that concentration of production is a major consideration in food supply chains. Theoretically, food items that are produced in only a few countries are at greater risk of supply disruption from the weather, local diseases or internal politics leading to export bans. In the chart below, Miss Materiality shows the share of global production of her grocery items by the top 5 and top 10 producing countries. She posits that those with the lowest concentration have a reduced risk of supply shortages. This is consistent with preceding charts, where the price of bananas and milk are the only prices that fell during the period (both have among the lowest concentration of production). Eggs are the exception to the assertion that low concentration reduces the risk of shortages which is explained by the effects of H5N1, a global disease.

 

Since Miss Materiality is doing as much as she can to adapt to higher food prices, she wonders if her investments could compensate for those higher costs. The map below shows the publicly-listed companies with strong sustainability practices that she could potentially invest in. For salmon, Mowi has strong sustainability practices and is a relatively low-cost producer. For soybeans which get transformed into tofu, House Group Food fits the bill. Adecoagro scores highly for a sugar producer, while JDE Peets is a positive standout for coffee and tea that is on pace to have 100% of its tea and coffee certified as responsible this year. For orange juice and olive oil, she did not find interesting candidates. For cocoa and meat, she cannot find attractive long candidates; she has a negative view on Mondelez, Tyson Foods and JBS. For eggs and bananas, she found four companies: Vital Farms, Cal Maine, Dole and Fresh Del Monte.

 

From an investment perspective, we agree with Miss Materiality that it is better to own low-cost producers in a concentrated industry where one can benefit from shortages. From that standpoint, MOWI, House Food Group, JDE Peets and Adecoagro are companies that are likely to benefit should a shortage occur in a related foodstuff. The chart below shows financial ratios for the companies mentioned above, with Cal-Maine and Adecoagro having the most attractive historical financial ratios. Miss Materiality is not surprised to see a company from an emerging market country, Adecoagro, in a concentrated industry with attractive financial ratios. Emerging markets have lagged developed markets over the last 15 years.

In terms of helping farmers and finding solutions that mitigate climate change risks with the view to stabilize prices, Miss Materiality found four leading irrigation companies with the greatest irrigation revenues as shown on the map below. Irrigation is key because droughts and excess heat can ravage crops. Miss Materiality could not believe that both, Valmont Industries and Lindsay Corporation are based in the home of Warren Buffett, Omaha, Nebraska.

Companies heavily involved in irrigation have comparable financial ratios, with the exception of Orbia Advance Corporation from Mexico, another company that operates in an emerging market. Note also that Orbia has a smaller exposure to irrigation compared to other companies in the chart. Beyond irrigation, Orbia is involved in other aspects of the chemical product industries.

 

Sustainable Market Strategies’ research team is an eclectic mix of analysts and strategists that are not afraid to debate contentious issues. One particularly contentious topic is gender; we note that the recent past has been bi-polar for gender issues. At one extreme, reproductive rights in the U.S. have been severely curtailed, leading to questions about the overall state of women’s rights. At the other extreme, the proliferation of women’s professional sports and a marked uptick in capital allocation to female health care suggest that some industries are becoming more gender balanced and are in fact providing potentially exciting investment opportunities.  

What follows in today’s Note is a summary position of our ongoing, internal debate regarding various gender issues (by no means a complete list) that have the potential to impact investment decisions.

 

True or False: The gender pay gap has deleterious effects on economic growth.

True. It’s no great secret that women earn less than men. The reasons behind this are many and range from blatant discrimination, sub-optimal parental benefits and structures and the preponderance of pink-collar industries, e.g. nursing and education, to be less lucrative than blue collar jobs (despite often requiring more advanced education). In the U.S., the gender pay gap has not budged in the past twenty years, though many other countries have made substantial progress.  

What would it mean for economic growth if the gender pay gap were to close? A lot. In 2023, Moody’s estimated that closing the gender gap in OECD countries would raise global economic activity by approximately 7%, or about $7 trillion USD.

Amazingly, the Moody’s report came up with this estimate solely based on the assumption that women could actually access the jobs that matched their education level. In most OECD countries and major emerging markets, the number of women aged 25 to 64 with a master’s degree or equivalent exceeds that of men.

And yet, as the chart below highlights, the proportion of women in senior and middle management positions is paltry compared to men. The implication is that the return on investment of education is sub-optimal and the underutilisation of women’s skills and time, causes an economic loss at both the individual and macroeconomic levels.

True or False: Women-run companies produce better financial returns

False: being female isn’t a superpower, but diversity is. The question of whether women-run companies produce better financial returns has garnered significant attention and research. We tackled this subject in a previous note in 2019 (“Gender Diversity: What’s the data telling us?”, August 8, 2019), which highlighted the difficulty of finding data points linking financial performance and gender diversity.

As discussed in the previous section, women are still far outnumbered in senior roles. They make up less than 10% of CEOs of S&P500 companies (see chart below).

In 2023 however, women CEOs had a breakthrough, finally outnumbering CEOs named John (!) as more women are taking the top job. This milestone reflects broader trends suggesting growing recognition that diversity in leadership positions is advantageous.

Indeed, research from McKinsey shows that diverse boards and executive teams are positively correlated with better non-financial performance, including higher social and environmental impact scores. Specifically, companies with increased gender diversity in leadership show improved performance in community, workforce, and environmental scores. The following chart highlights how a 10% increase in women’s representation on leadership teams correlates with higher scores across various impact metrics.

While women-led companies often see strong financial returns, the true driver of success is the diversity they bring—encompassing varied perspectives and cognitive multiplicity.

 

True or False: Women sports teams are having a breakout moment and it matters for investors.

True. Fueled by shakeups in media consumption, women’s professional sports are experiencing significant growth and popularity.

Recent years have shown how more diverse content can be a driver of success. Netflix’s business model is a key example: more varied programming has helped to uncover audiences previously neglected by traditional content creators and video streaming facilitates access to this content. Just like Netflix did for film and television programs, the proliferation of women’s teams boosts diversity in sports entertainment, therefore drawing in a wider audience. Social media has further bolstered the impact of these changes by delivering tailored content to target likely fans. And female athletes who previously faced a coverage gap compared to their male counterparts can now connect directly with supporters via social media platforms.

The result has been a spike in popularity for women’s sports. Momentum from a record setting 2023 has carried into this year. The Professional Women’s Hockey League (PWHL) kicked off its inaugural season. Initially scheduled in smaller arenas, sold out venues prompted organizers to move some games to larger capacity locations including the largest hockey arena in North America: the Bell Centre (which also sold out). At just the midpoint of its 11th season, the National Women’s Soccer League (NWSL) attendance had increased 42% over last year’s record numbers and merchandise sales were up a staggering 290%! The Kansas City Current became the first NWSL team to have their own dedicated home stadium. Financed with support from JP Morgan, the ownership brings more control and choice, helping to unlock new revenue streams and drive growth. It is seen as a template for other teams to follow. And in basketball, (if you hadn’t heard already), the women’s march madness final drew in nearly 4 million more viewers than the men’s championship game. This wave of enthusiasm is expected to have a ripple effect on the WNBA as top college players enter the professional league.

These previously unmeasured metrics (thanks to a lack of coverage for women’s sports) suggest significant growth prospects. A report by Deloitte released at the end of last year projects women’s sports to earn over $1 billion USD in 2024, some 300% higher than their forecast from 2021, underscoring the immense upside potential. Though past iterations of women’s leagues have folded, today’s teams are supported by a changed media landscape and a flywheel effect in full swing (see diagram below). With sponsors and broadcasters already taking notice, this self-reinforcing cycle suggests the momentum behind women’s sports is here to stay. As market value continues to rise, there is the potential for valuation convergence with men’s sports.

Investment opportunities in women's sports primarily lie in the private equity space, as there are few pure plays in publicly traded companies. However, as viewership increases, so does the potential for merchandise and sponsorship deals, leading to revenue growth for broadcasters, stadiums, concessions and jersey sales. Though the companies in these segments predominately serve men’s teams (at least historically), their allyship is a key step forward.

 

True or False: Women have been shortchanged in health care and an investment catch-up phase is likely.

True. Health care is another area where a prevailing data gap has adversely affected women. Historically, women have been consistently underrepresented in medical research. There are issues of overreliance on male mice for preclinical studies, an insufficient number of women at the trial stage and failure to account for sex-based differences in outcomes (all of which are well documented in Criado-Perez’s book Invisible Women). Furthermore, when it comes to female-specific ailments, research is extremely underfunded. A 2022 McKinsey report showed that, excluding women’s cancers, only 1% of health care research spending is focused on female-specific conditions (women’s cancers receive 4%). As recently as 2015, studies on erectile dysfunction (affecting 19% of the male population) outnumbered studies on premenstrual syndrome (affecting 90% of women) by three times!

Signs of a catch-up are beginning to emerge. This year alone, the Global Alliance for Women’s Health was launched at the World Economic forum in Davos; in March, Biden signed an executive order prioritizing women's health research and a significant portion of Melinda French Gates’ announced donation of $1 billion towards women’s causes is specifically tagged for health projects. Such initiatives should provide momentum to ongoing efforts, help to spur further action and encourage greater investment in women’s health research.

As this wall of money floods the sector, both start-ups and existing companies that focus on treating female-specific maladies will benefit. Operating in a more nascent industry, women’s health companies are at earlier phases of development. These could be prime candidates for acquisition by larger, more established health care players. There are a number of female-focused companies under $1 billion USD in market cap. Alternatively, investors can study how the major pharmaceutical companies are incorporating women’s health into their growth strategies. Are their acquisitions and R&D spend being directed to women’s health solutions?

Two of the largest publicly traded companies in women’s health are Hologic (market capitalization of $17 billion USD) and Organon ($5 billion USD). Hologic operates as a health care equipment company specializing in diagnostics, focusing on products such as mammography and breast biopsy systems as well as skeletal health and gynecological surgical devices. Like other health care companies, Hologic experienced outsized sales during the pandemic from its Covid diagnostics test product, but growth in its more female-centric segments remained strong in 2023. Organon is in the pharmaceuticals sector, concentrating on reproductive health and hormone therapy. Its stock price has struggled somewhat since the spinoff from Merck in 2021 but is rebounding in this first half of 2024. In terms of valuation, Organon comes at a much lower valuation (FWD P/E 4.5) than Hologic (FWD P/E 17.1) and the SP500 Healthcare sector (FWD P/E 19.1).

 

True or False: The Pink Tax Is real and presents a business risk to some consumer discretionary companies if it were “abolished”.

True, but it is an overstated risk. The pink tax refers to the tendency for products marketed specifically toward women to be more expensive than those marketed toward men and the phenomenon is often attributed to gender-based price discrimination. If it exists, the ramifications are quite obvious. First, from a consumer perspective, it would mean that women – who already suffer from an income and pension gap – have a higher cost of living than men, all else equal. Second, it means that companies using this strategy can generate higher profit margins based on discriminatory pricing and would be at risk of margin squeeze if/when the practice were to be abolished (either via consumer or shareholder pressure or a regulatory change).

Much of the pink tax attention has focused on personal care products whereby gender segmentation is ubiquitous, as more than 80% of products in this category are gendered. Various studies show pricing discrepancies exist, although some argue it is for valid reasons, e.g. product composition, women’s higher willingness to pay for quality. Studies in Argentina, the U.S., the U.K. and Canada all show evidence of this practice with the price gap of various consumer goods products averaging between 5 and 20%. 

Attempts to do anything about gender pricing have been mostly futile from a regulatory perspective. There are two U.S. states (NY and California) that explicitly outlaw a “pink tax”. At the U.S. federal level, the Pink Tax Repeal Act, has been introduced several times in different iterations since 2016, most recently in 2021, but has never passed. We are not aware of regulation regarding the pink tax elsewhere in the world.

In any case, personal care product companies do not view gendered pricing as a problem or risk to their business. Using Bloomberg’s “docusearch” tool, we find only a handful of companies addressing the pink tax in any sort of way. In the personal care segment, only CVS Health (CVS), Boxed and Billie (the latter two are private companies) are flagged as addressing the issue.

The bottom line is that for investors, absent meaningful consumer pressure, there is low risk that a meaningful change in pricing strategy would negatively impact profits (we did not find any companies that divulge profit margins disaggregated by gendered sales).

 

True or False: Women’s rights are regressing and it matters for capital markets 

False. Media coverage on the threat to abortion access in the United States is surely overshadowing progress in gender equality that has been achieved in recent decades (at least in the developed world). To be sure, the U.S. is not alone. In Italy, the rise of right-wing political forces has led to increased opposition to reproductive rights and other gender equality measures. And we note that there is a correlation between far-right uprisings and regression of women’s reproductive rights.

The threat to reproductive rights should absolutely be taken seriously, but there have nonetheless been substantial progress on several women’s rights issues, including reproductive rights. Most recently, France became the first country to enshrine women’s right to abortion in their constitution.

Though women still hold a minority of positions in government, there has been some progress in this area, as shown in the chart below. Mexico serves as a powerful example of the effectiveness of representation: five years ago, a constitutional reform required equal numbers of male and female candidates for government positions. In 2024, both of the country’s top political parties chose female candidates as their presidential nominees!

Women are also making gains in the boardroom as discussed in the previous sections. And despite a persistent wage gap, data from the United States shows that women who entered the workforce in 1983 have seen their lifetime earnings increase 33% in real terms compared to the previous generation (for the same period, men can expect to earn 10% less).

Still, according to the World Economic Forum’s report on the global gender gap, it will take 134 years for women to reach full parity globally at the current rate of progress. Given that gender parity would, as highlighted above, significantly increase economic output and prosperity, there is a massive incentive to more rapidly close this gap. Investing in areas that promote gender equality is just one way to contribute to reducing this disparity, and the widening opportunity set shows increasing promise.